In non-small cell lung cancer research on anti-tumor drug resistance (Jiang M. et al., 2022; Jiang Y. et al., 2022), the C4/HSA-C4 NP plays a pivotal role. This evidence concerns the gene C4A and non-small cell lung carcinoma.